Method Development and Validation of Newer Analytical Methods as per ICH Guidelines

dc.contributor.guideVetrichelvan T
dc.coverage.spatial
dc.creator.researcherMurugan S
dc.date.accessioned2023-01-27T05:01:51Z
dc.date.available2023-01-27T05:01:51Z
dc.date.awarded2022
dc.date.completed2021
dc.date.registered2016
dc.description.abstractThe proposed analytical methods are simple, accurate and reproducible. The advantages lie in the simplicity of sample preparation and the cost economic reagents used. The single/combined dosage forms selected for the present study are Sonidegib, Sacubitril and Valsartan, Emtricitabine and Tenofovir alafenamide and Perindopril arginine and Amlodipine besylate in capsule/tablets. These combinations have recently entered into the market. Sonidegib is used as an Anticancer agent. Sacubitril and Valsartan combination is used as an Antihypertensive agent. Emtricitabine and Tenofovir alafenamide combination is used as an Antiretroviral agent. In the view of literature cited for the estimation of above mentioned single/combination of drugs, it was found that the methods for the estimation of Sonidegib, Sacubitril, Valsartan, Emtricitabine, Tenofovir alafenamide, Perindopril arginine and Amlodipine besylate in capsule/tablets single or combined with other drugs were available. There is no method was available for the determination of the single/combined dosage forms with the solvents employed for the analytical studies. The aim of my present work is to develop a precise accurate and simple methods for the estimation of Sonidegib, Sacubitril and Valsartan, Emtricitabine and Tenofovir alafenamide and Perindopril arginine and Amlodipine besylate in API and in single or combined formulation and to validated the developed methods by Ultra-Violet Spectrophotometry, Reverse Phase High-Performance Liquid Chromatography and High-Performance Thin Layer Chromatography or by any two methods. The overall scope and plan of the research work is to develop the methods for new drug combinations enter into the market and to validate the newer analytical methods as per International Conference on Harmonisation (ICH) guidelines. In developed methods the various parameters used to validate are: Linearity, Precision, Range, Reproducibility, Repeatability Accuracy, Limit of Quantitation, Limit of Detection and Ruggedness.
dc.description.note
dc.format.accompanyingmaterialNone
dc.format.dimensions
dc.format.extent270
dc.identifier.urihttp://hdl.handle.net/10603/453373
dc.languageEnglish
dc.publisher.institutionDepartment of Pharmacy
dc.publisher.placeChennai
dc.publisher.universityThe Tamil Nadu Dr. M.G.R. Medical University
dc.relation
dc.rightsuniversity
dc.source.universityUniversity
dc.subject.keywordDevelopment
dc.subject.keywordICH Guidelines
dc.subject.keywordMethod
dc.subject.keywordNewer Analytical Methods
dc.subject.keywordValidation
dc.titleMethod Development and Validation of Newer Analytical Methods as per ICH Guidelines
dc.title.alternative
dc.type.degreePh.D.

Files

Original bundle

Now showing 1 - 5 of 12
Loading...
Thumbnail Image
Name:
01_title.pdf
Size:
91.9 KB
Format:
Adobe Portable Document Format
Description:
Attached File
Loading...
Thumbnail Image
Name:
02_prelim pages.pdf
Size:
261.43 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
03_content.pdf
Size:
25.07 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
05_chapter 1.pdf
Size:
289.46 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
06_chapter 2.pdf
Size:
62.59 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: